Siemens is reassessing its majority stake in Healthineers, according to a report by Handelsblatt, with its CFO shedding light on the situation.

Siemens, a German multinational conglomerate, is reviewing its majority stake in Healthineers, a leading provider of digital healthcare solutions. This decision comes after Siemens reached a deal to sell a 15% stake in Healthineers to the public. The company’s CFO, Ralf Thomas, told German publication Handelsblatt that the review is aimed at assessing the best way to unlock value for Siemens’ shareholders. Thomas emphasized that the company is not planning to sell its majority stake, but rather considering options to increase liquidity and boost value. Healthineers, which went public in June 2016, has been a highly successful investment for Siemens. The company’s shares have more than tripled since its initial public offering. The review is part of Siemens’ efforts to streamline its portfolio and focus on its core business. Thomas stated that the company is discussing various options, including a potential initial public offering (IPO) for Healthineers, but no final decisions have been made. The review is expected to be completed in the coming weeks.